Quantcast
Tag archive for ‘FDA’
By Guest Author On Tuesday, June 6th, 2017
2 Comments

What To Know About the EpiPen Right Now

The EpiPen has been a source of tremendous controversy over the past year. Manufactured by the Mylan company, the EpiPen is a medical device available by prescription designed to inject doses of epinephrine through More...

By Guest Author On Sunday, May 21st, 2017
1 Comment

Dietary Supplements: The Face of a Self-Regulating Industry

The pressure to look great weighs heavily on many. From people who want to lose weight to improve their overall health to those who want to lose weight to fit their ideal beauty standards, the dietary supplement More...

By Guest Author On Friday, May 12th, 2017
1 Comment

The Different Treatment Approaches for Drug Addiction

Finding the most suitable treatment approach for drug addiction victims is an overwhelming task for both addicts and their family members. The task in itself may seem impossibly to achieve. Some patients take years More...

By Guest Author On Wednesday, April 5th, 2017
0 Comments

GlaxoSmithKline Urges Third Circuit to Ignore Ruling in Fosamax Case

GlaxoSmithKline PLC has asked the Third Circuit Appeals Court to ignore the ruling in a product liability case involving the drug Fosamax when deciding whether to revive a suit brought on by buyers of Wellbutrin. More...

By Guest Author On Thursday, January 12th, 2017
0 Comments

Syracuse Clinic Treats Head Lice with Hot Air

A head lice clinic in Syracuse, New York is taking a new approach to treatment: hot air. The treatment is designed to give patients an alternative to conventional treatments that include pesticide-based shampoos, More...

By Butter Bracco On Tuesday, January 10th, 2017
0 Comments

Praise for the REINS Act as it moves to the Senate, ‘restoring Article I of the Constitution’ ‘reclaiming its legislative power’

Following the passage of the Regulations from the Executive in Need of Scrutiny (REINS) Act, H.R. 26, FreedomWorks CEO Adam Brandon commented: “We’re pleased to see regulatory reform be the focus of the first More...

By The Dispatch On Saturday, December 17th, 2016
0 Comments

Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)

Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine.  More...

By Butter Bracco On Wednesday, June 8th, 2016
0 Comments

US Senate to fine pharmacists who refuse to dispense Plan B

Senate Democrats have introduced a bill that would impose crushing fines on pharmacists who refuse to personally dispense Plan B pills, an “emergency contraception,” and a potential abortifacient, removing conscience More...

By Laura Jones On Thursday, March 31st, 2016
0 Comments

FDA passes Mifeprex changes, reducing cost for abortions despite risk to women

The Food and Drug Association (FDA) changed the regimen for mifepristone (Mifeprex), significantly reducing the obstacles, burden, and cost to abortionists. The move includes approval of new labeling for the abortion More...

By The Dispatch On Wednesday, December 23rd, 2015
0 Comments

New Hampshire: state loses valid ‘right to know’ battle over Planned Parenthood delays

A New Hampshire court ruled Tuesday that the state’s Department of Health and Human Services was wrong to wait for permission from Planned Parenthood before releasing documents the agency was legally required More...

By The Dispatch On Monday, September 14th, 2015
1 Comment

ADF files brief to make New Hampshire funding of Planned Parenthood records public

Alliance Defending Freedom attorneys filed a brief with the New Hampshire Supreme Court Wednesday to release all documents related to the state’s funding of abortion facilities and its continuing failure to regulate More...

By Guest Author On Tuesday, September 8th, 2015
0 Comments

Prevalent Poison: The Shocking Stats Behind Nursing Home Drugging

When people send their loved ones to a nursing home, they expect that they will be taken care of. But, some new findings suggest that elderly patients are being abused in these facilities. Here are some ways to More...

By Guest Author On Thursday, August 20th, 2015
1 Comment

The Same Scams Target Vulnerable Older People in 2015

On a regular basis, we read about companies and individuals charged with investment fraud and Ponzi-like schemes. Recent ones include Atlanta-based Gray Financial Group, Inc. for putting pension plans in an investment More...

By The Dispatch On Tuesday, November 25th, 2014
1 Comment

Restaurant menu and vending machine calorie labeling rules finalized

The U.S. Food and Drug Administration today finalized two rules requiring that calorie information be listed on menus and menu boards in chain restaurants, similar retail food establishments and vending machines More...

By Guest Author On Tuesday, August 19th, 2014
1 Comment

Vacations and Health – The new winning formula for travelers abroad

Many people around the world who simply cannot afford to undergo a medical procedure at home, due to a complex medical procedure or a simple cosmetic one, have got an opportunity to go to a foreign country and have More...

By Robert Herriman On Wednesday, July 30th, 2014
2 Comments

NC physician petitions FDA to ‘fast-track’ Tekmira’s Ebola drug

With the Ebola Virus Disease (EVD) raging through West Africa resulting in the largest outbreak of the lethal disease since first found in 1976, one North Carolina physician is petitioning the Food and Drug Administration More...

By The Dispatch On Wednesday, July 23rd, 2014
0 Comments

Schwebel’s announce recall of certain products from Youngstown bakery

Schwebel Baking Company today announced it has voluntarily withdrawn certain products from the marketplace after Listeria was discovered during a scheduled environmental assessment of its Youngstown bakery. Schwebel More...

By The Dispatch On Thursday, May 29th, 2014
0 Comments

Tanning beds and tanning booths to require warning because of cancer risk: FDA

PRESS RELEASE Today, the U.S. Food and Drug Administration issued a final order reclassifying sunlamp products and ultraviolet (UV) lamps intended for use in sunlamp products from low-risk (class I) to moderate-risk More...

By Robert Herriman On Thursday, May 15th, 2014
0 Comments

Sleep drug, Lunesta, to be relabeled with lower starting dose: FDA

PRESS RELEASE The U.S. Food and Drug Administration today announced it required the manufacturer of the sleep drug Lunesta (eszopiclone) to change the drug label and lower the current recommended starting dose. More...

By The Dispatch On Wednesday, April 16th, 2014
0 Comments

Experts express concern about use of Stanislaw Burzynski’s ‘antineoplastons’ for cancer treatment

A group of medical, scientific and policy experts joined forces with the Center for Inquiry (CFI) in sending a letter to Food and Drug Administration (FDA) Commissioner, Margaret A. Hamburg, MD expressing concern More...


Recent Posts


DISPATCH BLOGS

Splash Page logo 300x146 Today in History